US4126680A
(en)
*
|
1977-04-27 |
1978-11-21 |
Pfizer Inc. |
Tetracycline antibiotic compositions
|
DE2963584D1
(en)
*
|
1978-08-01 |
1982-10-21 |
Ciba Geigy Ag |
Stable, liquid pharmaceutical formulation, its preparation and use
|
DE2965917D1
(en)
*
|
1978-12-08 |
1983-08-25 |
Beecham Group Plc |
A process for the preparation of a solid sodium amoxycillin and aqueous solutions thereof
|
US4259331A
(en)
*
|
1979-04-16 |
1981-03-31 |
Pfizer Inc. |
Oxytetracycline compositions
|
IE49934B1
(en)
*
|
1979-07-02 |
1986-01-08 |
Pfizer |
Long acting sulfonamide injectable compositions
|
US4303643A
(en)
*
|
1979-07-05 |
1981-12-01 |
Pfizer Inc. |
Sulfonamide compositions
|
ATE3750T1
(de)
*
|
1979-07-05 |
1983-06-15 |
Pfizer Inc. |
Sulfonamidloesungen.
|
US4386083A
(en)
*
|
1980-04-10 |
1983-05-31 |
Walter Hacke |
Injectable oxytetracycline compositions
|
CA1163197A
(fr)
*
|
1980-04-10 |
1984-03-06 |
Herman Horn |
Composes d'oxytetracycline injectables
|
US4399127A
(en)
*
|
1980-04-10 |
1983-08-16 |
Diamond Shamrock Corporation |
Injectable oxytetracycline compositions
|
US4374826A
(en)
*
|
1980-07-21 |
1983-02-22 |
Pfizer Inc. |
Sulfonamide compositions
|
NL178941C
(nl)
*
|
1982-06-15 |
1986-06-16 |
Aesculaap Bv |
Werkwijze voor de bereiding van een waterig oxytetracyclinepreparaat.
|
US4769232A
(en)
*
|
1984-03-22 |
1988-09-06 |
Pfizer Inc. |
Parenteral formulations of indolmycin
|
IE74244B1
(en)
*
|
1985-10-01 |
1997-07-16 |
Bimeda Res Dev Ltd |
A process for preparing an antibiotic composition
|
HU194493B
(en)
*
|
1985-11-27 |
1988-02-29 |
Chinoin Gyogyszer Es Vegyeszet |
Process for preparing primycin-containing colloidal basic gel and compositions comprising the same
|
FR2608044B1
(fr)
*
|
1986-12-10 |
1992-09-11 |
Sogeval |
Composition antibiotique aqueuse a usage veterinaire
|
US4906475A
(en)
*
|
1988-02-16 |
1990-03-06 |
Paco Pharmaceutical Services |
Estradiol transdermal delivery system
|
US6756365B2
(en)
*
|
1991-11-06 |
2004-06-29 |
Trustees Of Tufts College |
Reducing tetracycline resistance in living cells
|
EP0626171A1
(fr)
*
|
1993-05-26 |
1994-11-30 |
Winfried Dörnhöfer |
Solution injectable à base d'oxytetracycline ou doxycycline contenant de la PVP et de la N-methylpyrrolidone et/ou de la 2-pyrrolidone
|
ES2130069B1
(es)
*
|
1997-04-10 |
2000-03-01 |
Basf Labiana S A |
Preparacion farmaceutica con liberacion retardada del producto activo.
|
US20020077276A1
(en)
*
|
1999-04-27 |
2002-06-20 |
Fredeking Terry M. |
Compositions and methods for treating hemorrhagic virus infections and other disorders
|
ATE323671T1
(de)
|
1999-09-14 |
2006-05-15 |
Tufts College |
Verfahren zur herstellung von substituierten tetracyclinen mit hilfe von auf übergangsmetalle basierten chemien
|
US6500812B2
(en)
|
1999-09-14 |
2002-12-31 |
Paratek Pharmaceuticals, Inc. |
13-substituted methacycline compounds
|
US6849615B2
(en)
|
1999-09-14 |
2005-02-01 |
Paratek Pharmaceuticals, Inc. |
13-substituted methacycline compounds
|
US8106225B2
(en)
*
|
1999-09-14 |
2012-01-31 |
Trustees Of Tufts College |
Methods of preparing substituted tetracyclines with transition metal-based chemistries
|
EP1255565A1
(fr)
*
|
2000-01-13 |
2002-11-13 |
MERCK PATENT GmbH |
Compositions pharmaceutiques contenant de la 2-pyrrolidone en tant qu'agent de solubilisation
|
CA2397863A1
(fr)
|
2000-01-24 |
2001-07-26 |
Trustees Of Tufts College |
Composes de tetracycline pour le traitement de troubles afferents au cryptosporidium parvum
|
EA200201046A1
(ru)
|
2000-03-31 |
2003-04-24 |
Трастис Оф Тафтс Коллидж |
7- или 9-замещенные соединения тетрациклина, способ их получения (варианты), фармацевтическая композиция, способ лечения состояния, чувствительного к действию тетрациклина, у млекопитающего и реакционноспособное промежуточное производное
|
US6642270B2
(en)
*
|
2000-05-15 |
2003-11-04 |
Paratek Pharmaceuticals, Inc. |
7-substituted fused ring tetracycline compounds
|
US20040224927A1
(en)
*
|
2000-06-16 |
2004-11-11 |
Trustees Of Tufts College |
7-N-substituted phenyl tetracycline compounds
|
US20020132798A1
(en)
*
|
2000-06-16 |
2002-09-19 |
Nelson Mark L. |
7-phenyl-substituted tetracycline compounds
|
WO2001098236A2
(fr)
*
|
2000-06-16 |
2001-12-27 |
Trustees Of Tufts College |
Composes de tetracycline 7-phenyl-substituee
|
US20050143353A1
(en)
*
|
2000-07-07 |
2005-06-30 |
Paratek Pharmaceuticals, Inc. |
13-Substituted methacycline compounds
|
US7094806B2
(en)
*
|
2000-07-07 |
2006-08-22 |
Trustees Of Tufts College |
7, 8 and 9-substituted tetracycline compounds
|
CN1452611A
(zh)
|
2000-07-07 |
2003-10-29 |
塔夫茨大学信托人 |
13-取代甲烯土霉素化合物
|
US6624168B2
(en)
|
2000-07-07 |
2003-09-23 |
Trustees Of Tufts College |
7,8 and 9-substituted tetracycline compounds
|
CZ2003343A3
(cs)
|
2000-07-07 |
2003-05-14 |
Trustees Of Tufts College |
7-Substituované tetracyklinové sloučeniny
|
ATE544745T1
(de)
|
2000-07-07 |
2012-02-15 |
Tufts College |
9-substituierte minocyclinverbindungen
|
AU2002250331A1
(en)
*
|
2001-03-13 |
2002-09-24 |
Paratek Pharmaceuticals, Inc. |
7-pyrollyl tetracycline compounds and methods of use thereof
|
CZ20032780A3
(cs)
|
2001-03-13 |
2004-01-14 |
Paratek Pharmaceuticals, Inc. |
7,9- Substituované tetracyklinové sloučeniny
|
US7553828B2
(en)
|
2001-03-13 |
2009-06-30 |
Paratek Pharmaceuticals, Inc. |
9-aminomethyl substituted minocycline compounds
|
EP1241160A1
(fr)
*
|
2001-03-13 |
2002-09-18 |
Glaxo Group Limited |
Dérivés de tétracyclines et leur utilisation comme agents antibiotiques
|
US7045507B2
(en)
|
2001-03-14 |
2006-05-16 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds as synergistic antifungal agents
|
US6841546B2
(en)
*
|
2001-03-14 |
2005-01-11 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds as antifungal agents
|
CA2444899C
(fr)
|
2001-04-24 |
2011-06-21 |
Paratek Pharmaceuticals, Inc. |
Composes de tetracycline substitues destines au traitement de la malaria
|
US8088820B2
(en)
*
|
2001-04-24 |
2012-01-03 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for the treatment of malaria
|
US20030181371A1
(en)
*
|
2001-12-28 |
2003-09-25 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods of using collajolie
|
AU2003235759A1
(en)
*
|
2002-01-08 |
2003-07-24 |
Paratek Pharmaceuticals, Inc. |
4-dedimethylamino tetracycline compounds
|
EP1482926A4
(fr)
|
2002-03-08 |
2006-04-12 |
Paratek Pharm Innc |
Composes a base de tetracycline a substitution aminomethyle
|
KR101025400B1
(ko)
|
2002-03-21 |
2011-03-28 |
파라테크 파마슈티컬스, 인크. |
치환된 테트라시클린 화합물
|
US6958161B2
(en)
|
2002-04-12 |
2005-10-25 |
F H Faulding & Co Limited |
Modified release coated drug preparation
|
AU2003261161B2
(en)
|
2002-07-12 |
2009-09-10 |
Paratek Pharmaceuticals, Inc |
3, 10, and 12a substituted tetracycline compounds
|
EP2277504A1
(fr)
|
2002-10-24 |
2011-01-26 |
Paratek Pharmaceuticals, Inc. |
Composes tetracycline substituee servant au traitement du paludisme
|
CN1732023A
(zh)
*
|
2002-12-27 |
2006-02-08 |
血管技术国际股份公司 |
组合物和使用collajolie的方法
|
US20060287283A1
(en)
*
|
2003-07-09 |
2006-12-21 |
Paratek Pharmaceuticals, Inc. |
Prodrugs of 9-aminomethyl tetracycline compounds
|
US20050137174A1
(en)
|
2003-07-09 |
2005-06-23 |
Paratek Pharmaceuticals, Inc. |
Prodrugs of 9-aminomethyl tetracycline compounds
|
EP2319829A1
(fr)
*
|
2003-07-09 |
2011-05-11 |
Paratek Pharmaceuticals, Inc. |
Composés tétracyclines substitués em position 9
|
AU2004261143B2
(en)
*
|
2003-07-25 |
2009-11-05 |
Allergan Pharmaceuticals International Limited |
A doxycycline metal complex in a solid dosage form
|
CA2553510C
(fr)
|
2004-01-15 |
2012-09-25 |
Paratek Pharmaceuticals, Inc. |
Derives a cycle aromatique a provenant de composes de tetracycline
|
TWI261038B
(en)
*
|
2004-08-11 |
2006-09-01 |
Bo-Cheng Chen |
Bicycle gear-shifting handgrip
|
CA2585418A1
(fr)
*
|
2004-10-25 |
2006-05-04 |
Paratek Pharmaceuticals, Inc. |
4-aminotetracyclines et procedes d'utilisation
|
EP2284151A3
(fr)
|
2004-10-25 |
2011-09-21 |
Paratek Pharmaceuticals, Inc. |
Composés de tétracycline substituée
|
AU2006206359B2
(en)
*
|
2005-01-21 |
2011-03-31 |
Allergan Pharmaceuticals International Limited |
A tetracycline metal complex in a solid dosage form
|
EP1848685A1
(fr)
|
2005-02-04 |
2007-10-31 |
Paratek Pharmaceuticals, Inc. |
Derives 11a, 12 de composes de tetracycline
|
US7919483B2
(en)
*
|
2005-06-24 |
2011-04-05 |
Medicis Pharmaceutical Corporation |
Method for the treatment of acne
|
US20080242642A1
(en)
|
2007-04-02 |
2008-10-02 |
Medicis Pharmaceutical Corporation |
Minocycline oral dosage forms for the treatment of acne
|
US7544373B2
(en)
*
|
2007-04-02 |
2009-06-09 |
Medicis Pharmaceutical Corporation |
Minocycline oral dosage forms for the treatment of acne
|
US20080241235A1
(en)
*
|
2007-04-02 |
2008-10-02 |
Medicis Pharmaceutical Corporation |
Minocycline oral dosage forms for the treatment of acne
|
US7541347B2
(en)
*
|
2007-04-02 |
2009-06-02 |
Medicis Pharmaceutical Coropration |
Minocycline oral dosage forms for the treatment of acne
|
US8252776B2
(en)
|
2007-04-02 |
2012-08-28 |
Medicis Pharmaceutical Corporation |
Minocycline oral dosage forms for the treatment of acne
|
US8722650B1
(en)
|
2005-06-24 |
2014-05-13 |
Medicis Pharmaceutical Corporation |
Extended-release minocycline dosage forms
|
AU2006272698B2
(en)
*
|
2005-07-21 |
2012-11-01 |
Paratek Pharmaceuticals, Inc. |
10-substituted tetracyclines and methods of use thereof
|
AU2007208214B2
(en)
*
|
2006-01-24 |
2013-02-14 |
Paratek Pharmaceuticals, Inc. |
Methods of increasing oral bioavailability of tetracyclines
|
US20070244335A1
(en)
*
|
2006-04-17 |
2007-10-18 |
Teva Pharmaceutical Industries Ltd. |
Isolation of tetracycline derivatives
|
PT2016045E
(pt)
*
|
2006-04-24 |
2015-02-05 |
Teva Pharma |
Forma cristalina de tigeciclina e processos para a sua preparação
|
US8198470B2
(en)
*
|
2006-04-24 |
2012-06-12 |
Teva Pharmaceutical Industries Ltd. |
Crystalline form II of tigecycline and processes for preparation thereof
|
EP2537934A3
(fr)
*
|
2006-05-15 |
2013-04-10 |
Paratek Pharmaceuticals, Inc. |
Procédés de régulation de lýexpression des gènes ou produits génétiques utilisant des composés tétracyclines substitués
|
US8440646B1
(en)
|
2006-10-11 |
2013-05-14 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for treatment of Bacillus anthracis infections
|
US8513223B2
(en)
|
2006-12-21 |
2013-08-20 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for treatment of inflammatory skin disorders
|
BRPI0720569B8
(pt)
|
2006-12-21 |
2021-05-25 |
Paratek Pharm Innc |
compostos de tetraciclina substituída e uso dos ditos compostos para o tratamento de uma infecção bacteriana, viral ou parasitária
|
US20080241197A1
(en)
*
|
2007-04-02 |
2008-10-02 |
Medicis Pharmaceutical Corporation |
Minocycline dosage forms for the treatment of acne
|
WO2008127722A1
(fr)
|
2007-04-12 |
2008-10-23 |
Paratek Pharmaceuticals, Inc. |
Procédés pour le traitement de l'amyotrophie spinale à l'aide de composés tétracyclines.
|
JP2010525069A
(ja)
|
2007-04-27 |
2010-07-22 |
パラテック ファーマシューティカルズ インコーポレイテッド |
アミノアルキルテトラサイクリン化合物の合成方法および精製方法
|
ES2386926T3
(es)
|
2007-07-06 |
2012-09-06 |
Paratek Pharmaceuticals, Inc. |
Métodos para sintetizar minociclina9-sustituida
|
US20090253660A1
(en)
|
2008-03-05 |
2009-10-08 |
Paratek Pharmaceuticals, Inc. |
Minocycline Compounds and Methods of Use Thereof
|
PT2271348T
(pt)
|
2008-03-28 |
2018-04-16 |
Paratek Pharm Innc |
Formulação de comprimido oral de composto de tetraciclina
|
AU2009236631A1
(en)
*
|
2008-04-14 |
2009-10-22 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
TW202216656A
(zh)
*
|
2008-05-23 |
2022-05-01 |
美商Prtk Spv2公司 |
四環素化合物之甲苯磺酸鹽及同素異形體
|
WO2010017310A1
(fr)
|
2008-08-06 |
2010-02-11 |
Medicis Pharmaceutical Corporation |
Procédé pour le traitement de l'acné, et certaines formes posologiques de celui-ci
|
AU2009292986A1
(en)
*
|
2008-09-19 |
2010-03-25 |
Paratek Pharmaceuticals, Inc. |
Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment
|
EP3061460A1
(fr)
|
2009-04-10 |
2016-08-31 |
Tufts Medical Center, Inc. |
Activation de par-1 par la métalloprotéinase-1 (mmp-1)
|
CN102970992B
(zh)
|
2010-05-12 |
2016-07-06 |
莱姆派克斯制药公司 |
四环素组合物
|
JP6574572B2
(ja)
|
2011-05-12 |
2019-09-11 |
パラテック ファーマシューティカルズ インコーポレイテッド |
(4s,4as,5ar,12as)−4−ジメチルアミノ−3,10,12,12a−テトラヒドロキシ−7−[(メトキシ(メチル)アミノ)−メチル]−1,11−ジオキソ−1,4,4a,5,5a,6,11,12a−オクタヒドロ−ナフタセン−2−カルボン酸アミドの結晶塩及びそれを使用する方法
|
US9561241B1
(en)
|
2011-06-28 |
2017-02-07 |
Medicis Pharmaceutical Corporation |
Gastroretentive dosage forms for minocycline
|
WO2015021387A2
(fr)
*
|
2013-08-09 |
2015-02-12 |
Britt George N |
Formulations pour le contrôle et la prévention de maladies parodontales et péri-implantaires et d'autres maladies et affections buccales, et procédés et systèmes d'administration supra- et sub-gingivale pour de telles formulations
|
CN103536530A
(zh)
*
|
2013-10-30 |
2014-01-29 |
王玉万 |
盐酸多西环素长效注射剂及制备方法
|
US9918998B2
(en)
|
2015-03-23 |
2018-03-20 |
BioPharmX, Inc. |
Pharmaceutical tetracycline composition for dermatological use
|
CN104721133B
(zh)
*
|
2015-04-14 |
2018-05-18 |
四川美嘉龙生物科技有限公司 |
一种土霉素制剂及制备方法
|
RU2019113715A
(ru)
|
2016-11-01 |
2020-12-03 |
Паратек Фармасьютикалс, Инк. |
9-аминометилминоциклиновые соединения и их применение для лечениия внебольничной бактериальной пневмонии(вбп)
|
CN111343991A
(zh)
|
2017-07-21 |
2020-06-26 |
阿尔米雷尔有限责任公司 |
非炎性病变的治疗
|
AU2018374490B2
(en)
|
2017-11-28 |
2024-05-16 |
New Matterhorn, Llc |
Method for producing trehalose employing a trehalose phosphorylase variant
|
US11426351B2
(en)
|
2019-12-26 |
2022-08-30 |
Sunstar Inc. |
Process for producing a pharmaceutical composition containing micro particles
|